{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:56:16Z","timestamp":1759056976667,"version":"3.37.3"},"reference-count":140,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["3-N-20\/21"],"award-info":[{"award-number":["3-N-20\/21"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting\npeople worldwide and is rapidly spreading and evolving. Day by day, the confirmed\ncases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited\ndata are available to curb the disease. Epidemiological approaches, such as isolation, quarantine,\nsocial distancing, lockdown, and curfew, are being employed to halt the spread of the disease.\nIndividual and joint efforts all over the world are producing a wealth of data and information\nwhich are expected to produce therapeutic strategies against COVID-19. Current research\nfocuses on the utilization of antiviral drugs, repurposing strategies, vaccine development,\nas well as basic to advanced research about the organism and the infection. The review\nfocuses on its life cycle, targets, and possible therapeutic strategies, which can lead to further\nresearch and development of COVID-19 therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327666200702151018","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T16:35:29Z","timestamp":1593707729000},"page":"2852-2886","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8712-4705","authenticated-orcid":true,"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-8649","authenticated-orcid":true,"given":"Seetha","family":"Harilal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah G.","family":"Al-Sehemi","sequence":"additional","affiliation":[{"name":"Research center for Advanced Materials Science, King Khalid University, 61413 Abha,Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-9552","authenticated-orcid":true,"given":"Githa Elizabeth","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Grace College of Pharmacy, Palakkad,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":true,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":true,"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e792","DOI":"10.1016\/j.ijid.2013.07.002","volume":"17","author":"Momattin H.","year":"2013","unstructured":"Momattin H.; Mohammed K.; Zumla A.; Memish Z.A.; Al-Tawfiq J.A.; Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis 2013,17(10),e792-e798","journal-title":"Int J Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","volume":"35","author":"Jiang F.","year":"2020","unstructured":"Jiang F.; Deng L.; Zhang L.; Cai Y.; Cheung C.W.; Xia Z.; Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020,35(5),1545-1549","journal-title":"J Gen Intern Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Wan Y.","year":"2020","unstructured":"Wan Y.; Shang J.; Graham R.; Baric R.S.; Li F.; Receptor Recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of sars coronavirus. J Virol 2020,94(7),e00127-e20","journal-title":"J Virol"},{"key":"ref=4","unstructured":"WHO says vaccines against novel coronavirus 18 months\naway, pushes global research. Available\nat  [accessed on: May 19, 2020]."},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"Holshue M.L.","year":"2020","unstructured":"Holshue M.L.; DeBolt C.; Lindquist S.; Lofy K.H.; Wiesman J.; Bruce H.; Spitters C.; Ericson K.; Wilkerson S.; Tural A.; Diaz G.; Cohn A.; Fox L.; Patel A.; Gerber S.I.; Kim L.; Tong S.; Lu X.; Lindstrom S.; Pallansch M.A.; Weldon W.C.; Biggs H.M.; Uyeki T.M.; Pillai S.K.; Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020,382(10),929-936","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"Liu K.","year":"2020","unstructured":"Liu K.; Fang Y-Y.; Deng Y.; Liu W.; Wang M-F.; Ma J-P.; Xiao W.; Wang Y-N.; Zhong M-H.; Li C-H.; Li G-C.; Liu H-G.; Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl) 2020,133(9),1025-1031","journal-title":"Chin Med J (Engl)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"Richardson P.","year":"2020","unstructured":"Richardson P.; Griffin I.; Tucker C.; Smith D.; Oechsle O.; Phelan A.; Stebbing J.; Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 2020,395(10223),e30-e31","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1871523019999200228100917","volume":"19","author":"Carradori S.","year":"2020","unstructured":"Carradori S.; Are there any therapeutic options currently available for Wuhan coronavirus? Antiinflamm Antiallergy Agents Med Chem 2020,19(2),85-87","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=9","unstructured":"WHO coronavirus disease (COVID-19) dashboard. Available\nat  [accessed on: May 19, 2020]."},{"key":"ref=10","unstructured":"WHO Gender and COVID-19: advocacy brief, 14 May\n2020. Available at  [accessed on: May 19, 2020]."},{"key":"ref=11","unstructured":"UN Women Data Hub, COVID-19: Emerging gender data\nand why it matters. Available at  [accessed on: May 19, 2020]."},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Liu Q.; Guo D.; Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 2020,92(4),418-423","journal-title":"J Med Virol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jmv.25688","volume":"92","author":"Benvenuto D.","year":"2020","unstructured":"Benvenuto D.; Giovanetti M.; Ciccozzi A.; Spoto S.; Angeletti S.; Ciccozzi M.; The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol 2020,92(4),455-459","journal-title":"J Med Virol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"Chan J.F-W.","year":"2020","unstructured":"Chan J.F-W.; Kok K-H.; Zhu Z.; Chu H.; To K.K-W.; Yuan S.; Yuen K-Y.; Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020,9(1),221-236","journal-title":"Emerg Microbes Infect"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"Hui D.S.","year":"2020","unstructured":"Hui D.S.; Azhar I.; E.; Madani, T.A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T.D.; Memish, Z.A.; Drosten, C.; Zumla, A.; Petersen, E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020,91,264-266","journal-title":"Int J Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X-L.; Wang X-G.; Hu B.; Zhang L.; Zhang W.; Si H-R.; Zhu Y.; Li B.; Huang C-L.; Chen H-D.; Chen J.; Luo Y.; Guo H.; Jiang R-D.; Liu M-Q.; Chen Y.; Shen X-R.; Wang X.; Zheng X-S.; Zhao K.; Chen Q-J.; Deng F.; Liu L-L.; Yan B.; Zhan F-X.; Wang Y-Y.; Xiao G-F.; Shi Z-L.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"Wu F.","year":"2020","unstructured":"Wu F.; Zhao S.; Yu B.; Chen Y-M.; Wang W.; Song Z-G.; Hu Y.; Tao Z-W.; Tian J-H.; Pei Y-Y.; Yuan M.L.; Zhang Y.L.; Dai F.H.; Liu Y.; Wang Q.M.; Zheng J.J.; Xu L.; Holmes E.C.; Zhang Y.Z.; A new coronavirus associated with human respiratory disease in China. Nature 2020,579(7798),265-269","journal-title":"Nature"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"Cui J.","year":"2019","unstructured":"Cui J.; Li F.; Shi Z-L.; Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019,17(3),181-192","journal-title":"Nat Rev Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1586\/14760584.2014.912134","volume":"13","author":"Zhang N.","year":"2014","unstructured":"Zhang N.; Jiang S.; Du L.; Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines 2014,13(6),761-774","journal-title":"Expert Rev Vaccines"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"Coutard B.","year":"2020","unstructured":"Coutard B.; Valle C.; de Lamballerie X.; Canard B.; Seidah N.G.; Decroly E.; The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020,176","journal-title":"Antiviral Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"Xia S.","year":"2020","unstructured":"Xia S.; Liu M.; Wang C.; Xu W.; Lan Q.; Feng S.; Qi F.; Bao L.; Du L.; Liu S.; Qin C.; Sun F.; Shi Z.; Zhu Y.; Jiang S.; Lu L.; Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 2020,30(4),343-355","journal-title":"Cell Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","volume":"17","author":"Xia S.","year":"2020","unstructured":"Xia S.; Zhu Y.; Liu M.; Lan Q.; Xu W.; Wu Y.; Ying T.; Liu S.; Shi Z.; Jiang S.; Lu L.; Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol 2020,17(7),765-767","journal-title":"Cell Mol Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.micinf.2020.01.003","volume":"22","author":"Yu F.","year":"2020","unstructured":"Yu F.; Du L.; Ojcius D.M.; Pan C.; Jiang S.; Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect 2020,22(2),74-79","journal-title":"Microbes Infect"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Zhang Y.; Wu L.; Niu S.; Song C.; Zhang Z.; Lu G.; Qiao C.; Hu Y.; Yuen K-Y.; Wang Q.; Zhou H.; Yan J.; Qi J.; Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 2020,181(4),894-904.e9","journal-title":"Cell"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"Lan J.","year":"2020","unstructured":"Lan J.; Ge J.; Yu J.; Shan S.; Zhou H.; Fan S.; Zhang Q.; Shi X.; Wang Q.; Zhang L.; Wang X.; Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020,581(7807),215-220","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"Shang J.","year":"2020","unstructured":"Shang J.; Ye G.; Shi K.; Wan Y.; Luo C.; Aihara H.; Geng Q.; Auerbach A.; Li F.; Structural basis of receptor recognition by SARS-CoV-2. Nature 2020,581(7807),221-224","journal-title":"Nature"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","volume":"10","author":"Kang S.","year":"2020","unstructured":"Kang S.; Yang M.; Hong Z.; Zhang L.; Huang Z.; Chen X.; He S.; Zhou Z.; Zhou Z.; Chen Q.; Yan Y.; Zhang C.; Shan H.; Chen S.; Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 2020,10(7),1228-1238","journal-title":"Acta Pharm Sin B"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"Neuman B.W.","year":"2011","unstructured":"Neuman B.W.; Kiss G.; Kunding A.H.; Bhella D.; Baksh M.F.; Connelly S.; Droese B.; Klaus J.P.; Makino S.; Sawicki S.G.; Siddell S.G.; Stamou D.G.; Wilson I.A.; Kuhn P.; Buchmeier M.J.; A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol 2011,174(1),11-22","journal-title":"J Struct Biol"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004077","volume":"10","author":"Nieto-Torres J.L.","year":"2014","unstructured":"Nieto-Torres J.L.; DeDiego M.L.; Verdi\u00e1-B\u00e1guena C.; Jimenez-Guarde\u00f1o J.M.; Regla-Nava J.A.; Fernandez-Delgado R.; Casta\u00f1o-Rodriguez C.; Alcaraz A.; Torres J.; Aguilella V.M.; Enjuanes L.; Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog 2014,10(5)","journal-title":"PLoS Pathog"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/pro.3873","volume":"29","author":"Kim Y.","year":"2020","unstructured":"Kim Y.; Jedrzejczak R.; Maltseva N.I.; Wilamowski M.; Endres M.; Godzik A.; Michalska K.; Joachimiak A.; Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci 2020,29(7),1596-1605","journal-title":"Protein Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"Li F.","year":"2005","unstructured":"Li F.; Li W.; Farzan M.; Harrison S.C.; Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005,309(5742),1864-1868","journal-title":"Science"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2017_25","author":"de Wilde A.H.","year":"2017","unstructured":"de Wilde A.H.; Snijder E.J.; Kikkert M.; van Hemert M.J.;  Roles of Host Gene and Non-coding RNA Expression in Virus Infection 2017,1-42","journal-title":"Roles of Host Gene and Non-coding RNA Expression in Virus Infection"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"Kim D.","year":"2020","unstructured":"Kim D.; Lee J-Y.; Yang J-S.; Kim J.W.; Kim V.N.; Chang H.; The architecture of SARS-CoV-2 transcriptome. Cell 2020,181(4),914-921.e10","journal-title":"Cell"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","volume":"24","author":"Shereen M.A.","year":"2020","unstructured":"Shereen M.A.; Khan S.; Kazmi A.; Bashir N.; Siddique R.; COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020,24,91-98","journal-title":"J Adv Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/3-540-26765-4_2","volume":"Vol. 287","author":"Sawicki S.G.","year":"2005","unstructured":"Sawicki S.G.; Sawicki D.L.;  Coronavirus replication and reverse genetics 2005,Vol. 287,31-55","journal-title":"Coronavirus replication and reverse genetics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1128\/JVI.79.9.5288-5295.2005","volume":"79","author":"Hussain S.","year":"2005","unstructured":"Hussain S.; Pan J.; Chen Y.; Yang Y.; Xu J.; Peng Y.; Wu Y.; Li Z.; Zhu Y.; Tien P.; Guo D.; Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J Virol 2005,79(9),5288-5295","journal-title":"J Virol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"14406","DOI":"10.1074\/jbc.RA119.008964","volume":"294","author":"Perrier A.","year":"2019","unstructured":"Perrier A.; Bonnin A.; Desmarets L.; Danneels A.; Goffard A.; Rouill\u00e9 Y.; Dubuisson J.; Belouzard S.; The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. J Biol Chem 2019,294(39),14406-14421","journal-title":"J Biol Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"Guo Y-R.","year":"2020","unstructured":"Guo Y-R.; Cao Q-D.; Hong Z-S.; Tan Y-Y.; Chen S-D.; Jin H-J.; Tan K-S.; Wang D-Y.; Yan Y.; The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020,7(1),11","journal-title":"Mil Med Res"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104759","volume":"177","author":"Sigrist C.J.","year":"2020","unstructured":"Sigrist C.J.; Bridge A.; Le Mercier P.; A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Res 2020,177","journal-title":"Antiviral Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"Alexopoulou L.","year":"2001","unstructured":"Alexopoulou L.; Holt A.C.; Medzhitov R.; Flavell R.A.; Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001,413(6857),732-738","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","volume":"32","author":"Wu J.","year":"2014","unstructured":"Wu J.; Chen Z.J.; Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014,32,461-488","journal-title":"Annu Rev Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"Wu J.","year":"2013","unstructured":"Wu J.; Sun L.; Chen X.; Du F.; Shi H.; Chen C.; Chen Z.J.; Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013,339(6121),826-830","journal-title":"Science"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"Seth R.B.","year":"2005","unstructured":"Seth R.B.; Sun L.; Ea C-K.; Chen Z.J.; Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005,122(5),669-682","journal-title":"Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"Ishikawa H.","year":"2008","unstructured":"Ishikawa H.; Barber G.N.; STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008,455(7213),674-678","journal-title":"Nature"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"Kawai T.","year":"2010","unstructured":"Kawai T.; Akira S.; The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010,11(5),373-384","journal-title":"Nat Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","volume":"334","author":"Bisht H.","year":"2005","unstructured":"Bisht H.; Roberts A.; Vogel L.; Subbarao K.; Moss B.; Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology 2005,334(2),160-165","journal-title":"Virology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3760\/cma.j.cn501120-20200224-00088","volume":"36","author":"Chen C.","year":"2020","unstructured":"Chen C.; Zhang X.R.; Ju Z.Y.; He W.F.; [Advances in the\nresearch of cytokine storm mechanism induced by Corona\nVirus Disease 2019 and the corresponding immunotherapies]. Zhonghua Shao Shang Za Zhi 2020,36(6),471-475","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Shi Y.","year":"2020","unstructured":"Shi Y.; Wang Y.; Shao C.; Huang J.; Gan J.; Huang X.; Bucci E.; Piacentini M.; Ippolito G.; Melino G.; COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020,27(5),1451-1454","journal-title":"Cell Death Differ"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Xu Z.","year":"2020","unstructured":"Xu Z.; Shi L.; Wang Y.; Zhang J.; Huang L.; Zhang C.; Liu S.; Zhao P.; Liu H.; Zhu L.; Tai Y.; Bai C.; Gao T.; Song J.; Xia P.; Dong J.; Zhao J.; Wang F.S.; Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020,8(4),420-422","journal-title":"Lancet Respir Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"Cao X.","year":"2020","unstructured":"Cao X.; COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020,20(5),269-270","journal-title":"Nat Rev Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Ye Q.","year":"2020","unstructured":"Ye Q.; Wang B.; Mao J.; The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19. J Infect 2020,80(6),607-613","journal-title":"J Infect"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"Chen G.","year":"2020","unstructured":"Chen G.; Wu D.; Guo W.; Cao Y.; Huang D.; Wang H.; Wang T.; Zhang X.; Chen H.; Yu H.; Zhang X.; Zhang M.; Wu S.; Song J.; Chen T.; Han M.; Li S.; Luo X.; Zhao J.; Ning Q.; Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020,130(5),2620-2629","journal-title":"J Clin Invest"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"Diao B.","year":"2020","unstructured":"Diao B.; Wang C.; Tan Y.; Chen X.; Liu Y.; Ning L.; Chen L.; Li M.; Liu Y.; Wang G.; Yuan Z.; Feng Z.; Zhang Y.; Wu Y.; Chen Y.; Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020,11,827","journal-title":"Front Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"Pedersen S.F.","year":"2020","unstructured":"Pedersen S.F.; Ho Y-C.; SARS-CoV-2: a storm is raging. J Clin Invest 2020,130(5),2202-2205","journal-title":"J Clin Invest"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"Moore J.B.","year":"2020","unstructured":"Moore J.B.; June C.H.; Cytokine release syndrome in severe COVID-19. Science 2020,368(6490),473-474","journal-title":"Science"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet HLH Across Speciality Collaboration2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jmv.25722","volume":"92","author":"Sun P.","year":"2020","unstructured":"Sun P.; Lu X.; Xu C.; Sun W.; Pan B.; Understanding of COVID-19 based on current evidence. J Med Virol 2020,92(6),548-551","journal-title":"J Med Virol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S2468-1253(20)30048-0","volume":"5","author":"Yeo C.","year":"2020","unstructured":"Yeo C.; Kaushal S.; Yeo D.; Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol 2020,5(4),335-337","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3201\/eid2606.200412","volume":"26","author":"Cai J.","year":"2020","unstructured":"Cai J.; Sun W.; Huang J.; Gamber M.; Wu J.; He G.; Indirect virus transmission in cluster of covid-19 cases, Wenzhou, China, 2020. Emerg Infect Dis 2020,26(6),1343-1345","journal-title":"Emerg Infect Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Bai Y.","year":"2020","unstructured":"Bai Y.; Yao L.; Wei T.; Tian F.; Jin D-Y.; Chen L.; Wang M.; Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020,323(14),1406-1407","journal-title":"JAMA"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMc2001737","volume":"382","author":"Zou L.","year":"2020","unstructured":"Zou L.; Ruan F.; Huang M.; Liang L.; Huang H.; Hong Z.; Yu J.; Kang M.; Song Y.; Xia J.; Guo Q.; Song T.; He J.; Yen H-L.; Peiris M.; Wu J.; SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020,382(12),1177-1179","journal-title":"N Engl J Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","volume":"382","author":"van Doremalen N.","year":"2020","unstructured":"van Doremalen N.; Bushmaker T.; Morris D.H.; Holbrook M.G.; Gamble A.; Williamson B.N.; Tamin A.; Harcourt J.L.; Thornburg N.J.; Gerber S.I.; Lloyd-Smith J.O.; de Wit E.; Munster V.J.; Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020,382(16),1564-1567","journal-title":"N Engl J Med"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30313-5","volume":"395","author":"Lu C.W.","year":"2020","unstructured":"Lu C.W.; Liu X.F.; Jia Z.F.; 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020,395(10224)","journal-title":"Lancet"},{"key":"ref=65","unstructured":"WHO. Report of the WHO-China Joint Mission on Coronavirus\nDisease 2019 (COVID-19). Available at:  [accessed on: May 19, 2020]."},{"year":"2021","key":"ref=66","unstructured":"CDC, Symptoms of Coronavirus, Available at:  [accessed on: May 19, 2020].2021"},{"key":"ref=67","unstructured":"Overview | coronavirus disease COVID-19. Available at:  [accessed on: May 19, 2020]."},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"Shi H.","year":"2020","unstructured":"Shi H.; Han X.; Jiang N.; Cao Y.; Alwalid O.; Gu J.; Fan Y.; Zheng C.; Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020,20(4),425-434","journal-title":"Lancet Infect Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(20)30113-4","volume":"20","author":"Pan Y.","year":"2020","unstructured":"Pan Y.; Zhang D.; Yang P.; Poon L.L.M.; Wang Q.; Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 2020,20(4),411-412","journal-title":"Lancet Infect Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"Rothe C.","year":"2020","unstructured":"Rothe C.; Schunk M.; Sothmann P.; Bretzel G.; Froeschl G.; Wallrauch C.; Zimmer T.; Thiel V.; Janke C.; Guggemos W.; Seilmaier M.; Drosten C.; Vollmar P.; Zwirglmaier K.; Zange S.; W\u00f6lfel R.; Hoelscher M.; Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020,382(10),970-971","journal-title":"N Engl J Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/infdis\/jiaa077","volume":"221","author":"Yu P.","year":"2020","unstructured":"Yu P.; Zhu J.; Zhang Z.; Han Y.; A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis 2020,221(11),1757-1761","journal-title":"J Infect Dis"},{"key":"ref=72","unstructured":"Detection of low level of COVID-19 virus in pet dog.\nAvailable at  [accessed on: May 19, 2020]."},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/vr.m1194","volume":"186","author":"Almendros A.","year":"2020","unstructured":"Almendros A.; Can companion animals become infected with Covid-19? Vet Rec 2020,186(12),388-389","journal-title":"Vet Rec"},{"key":"ref=74","unstructured":"Pet dog tests positive for COVID-19 virus. Available at:  [accessed on: May 19, 2020]."},{"key":"ref=75","unstructured":"Promed Post \u2013 ProMED-Mail. Available at:  [accessed on: May 19, 2020]."},{"key":"ref=76","unstructured":"Coronavirus: Belgium reaches 7,284 confirmed cases.\nAvailable at:  [accessed on: May 19, 2020]."},{"key":"ref=77","unstructured":"Pet cat tests positive for COVID-19. Available at:  [accessed on: May 19, 2020]."},{"author":"James A.","key":"ref=78","unstructured":"James A.; A Tiger at Bronx Zoo Tests Positive for COVID-19. Available at:  [accessed on:\nMay 19, 2020]."},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2020.100133","volume":"10","author":"Leroy E.M.","year":"2020","unstructured":"Leroy E.M.; Ar Gouilh M.; Brug\u00e8re-Picoux J.; The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic. One Health 2020,10","journal-title":"One Health"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.abb7015","volume":"368","author":"Shi J.","year":"2020","unstructured":"Shi J.; Wen Z.; Zhong G.; Yang H.; Wang C.; Huang B.; Liu R.; He X.; Shuai L.; Sun Z.; Zhao Y.; Liu P.; Liang L.; Cui P.; Wang J.; Zhang X.; Guan Y.; Tan W.; Wu G.; Chen H.; Bu Z.; Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 2020,368(6494),1016-1020","journal-title":"Science"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1354\/vp.45-4-551","volume":"45","author":"van den Brand J.M.A.","year":"2008","unstructured":"van den Brand J.M.A.; Haagmans B.L.; Leijten L.; van Riel D.; Martina B.E.; Osterhaus A.D.; Kuiken T.; Pathology of experimental SARS coronavirus infection in cats and ferrets. Vet Pathol 2008,45(4),551-562","journal-title":"Vet Pathol"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.01.021196","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Zhang H.; Huang K.; Yang Y.; Hui X.; Gao J.; He X.; Li C.; Gong W.; Zhang Y.; Peng C.; Gao X.; Chen H.; Zou Z.; Shi Z.; Jin M.; SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation. bioRxiv preprint.2020","journal-title":"bioRxiv"},{"key":"ref=83","unstructured":"2 cats in NY become first US pets to test positive for virus.\nAvailable at:  [accessed on: May 19, 2020]."},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/nejmc2013400","volume":"383","author":"Halfmann P.J.","year":"2020","unstructured":"Halfmann P.J.; Hatta M.; Chiba S.; Maemura T.; Fan S.; Takeda M.; Kinoshita N.; Hattori S.; Sakai-Tagawa Y.; Iwatsuki-Horimoto K.; Imai M.; Kawaoka Y.; Transmission of SARS-CoV-2 in domestic cats. N Engl J Med 2020,383(6),592-594","journal-title":"N Engl J Med"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101737","volume":"35","author":"Wang H.","year":"2020","unstructured":"Wang H.; Wang F.; Wang H.; Zhao Q.; Potential infectious risk from the pets carrying SARS-CoV-2. Travel Med Infect Dis 2020,35","journal-title":"Travel Med Infect Dis"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"Zheng Y-Y.","year":"2020","unstructured":"Zheng Y-Y.; Ma Y-T.; Zhang J-Y.; Xie X.; COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020,17(5),259-260","journal-title":"Nat Rev Cardiol"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"Fang L.","year":"2020","unstructured":"Fang L.; Karakiulakis G.; Roth M.; Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020,8(4)","journal-title":"Lancet Respir Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/23744235.2020.1729403","volume":"52","author":"Nilsson A.","year":"2020","unstructured":"Nilsson A.; Edner N.; Albert J.; Ternhag A.; Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Infect Dis (Lond) 2020,52(6),419-422","journal-title":"Infect Dis (Lond)"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3174\/ajnr.a6526","volume":"41","author":"Mahajan A.","year":"2020","unstructured":"Mahajan A.; Hirsch J.A.; Novel coronavirus: what neuroradiologists as citizens of the world need to know. AJNR Am Soc Neuroradiology 2020,41(4),552-554","journal-title":"AJNR Am Soc Neuroradiology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"Qin C.","year":"2020","unstructured":"Qin C.; Zhou L.; Hu Z.; Zhang S.; Yang S.; Tao Y.; Xie C.; Ma K.; Shang K.; Wang W.; Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020,71(15),762-768","journal-title":"Clin Infect Dis"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"Monteil V.","year":"2020","unstructured":"Monteil V.; Kwon H.; Prado P.; Hagelkr\u00fcys A.; Wimmer R.A.; Stahl M.; Leopoldi A.; Garreta E.; Hurtado Del Pozo C.; Prosper F.; Romero J.P.; Wirnsberger G.; Zhang H.; Slutsky A.S.; Conder R.; Montserrat N.; Mirazimi A.; Penninger J.M.; Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 2020,181(4),905-913.e7","journal-title":"Cell"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s13238-020-00718-6","volume":"11","author":"Zhao B.","year":"2020","unstructured":"Zhao B.; Ni C.; Gao R.; Wang Y.; Yang L.; Wei J.; Lv T.; Liang J.; Zhang Q.; Xu W.; Xie Y.; Wang X.; Yuan Z.; Liang J.; Zhang R.; Lin X.; Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell 2020,11(10),771-775","journal-title":"Protein Cell"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/nejmc2011400","volume":"383","author":"Puelles V.G.","year":"2020","unstructured":"Puelles V.G.; L\u00fctgehetmann M.; Lindenmeyer M.T.; Sperhake J.P.; Wong M.N.; Allweiss L.; Chilla S.; Heinemann A.; Wanner N.; Liu S.; Braun F.; Lu S.; Pfefferle S.; Schr\u00f6der A.S.; Edler C.; Gross O.; Glatzel M.; Wichmann D.; Wiech T.; Kluge S.; Pueschel K.; Aepfelbacher M.; Huber T.B.; Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020,383(6),590-592","journal-title":"N Engl J Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","volume":"46","author":"Pan X.W.","year":"2020","unstructured":"Pan X.W.; Xu D.; Zhang H.; Zhou W.; Wang L.H.; Cui X.G.; Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020,46(6),1114-1116","journal-title":"Intensive Care Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","volume":"6","author":"Liu C.","year":"2020","unstructured":"Liu C.; Zhou Q.; Li Y.; Garner L.V.; Watkins S.P.; Carter L.J.; Smoot J.; Gregg A.C.; Daniels A.D.; Jervey S.; Albaiu D.; Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci 2020,6(3),315-331","journal-title":"ACS Cent Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","volume":"14","author":"Dong L.","year":"2020","unstructured":"Dong L.; Hu S.; Gao J.; Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020,14(1),58-60","journal-title":"Drug Discov Ther"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/asia.201900841","volume":"14","author":"De Clercq E.","year":"2019","unstructured":"De Clercq E.; New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem Asian J 2019,14(22),3962-3968","journal-title":"Chem Asian J"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"Sheahan T.P.","year":"2020","unstructured":"Sheahan T.P.; Sims A.C.; Leist S.R.; Sch\u00e4fer A.; Won J.; Brown A.J.; Montgomery S.A.; Hogg A.; Babusis D.; Clarke M.O.; Spahn J.E.; Bauer L.; Sellers S.; Porter D.; Feng J.Y.; Cihlar T.; Jordan R.; Denison M.R.; Baric R.S.; Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020,11(1),222","journal-title":"Nat Commun"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/nejmoa2001282","volume":"82","author":"Cao B.","year":"2020","unstructured":"Cao B.; Wang Y.; Wen D.; Liu W.; Wang J.; Fan G.; Ruan L.; Song B.; Cai Y.; Wei M.; Li X.; Xia J.; Chen N.; Xiang J.; Yu T.; Bai T.; Xie X.; Zhang L.; Li C.; Yuan Y.; Chen H.; Li H.; Huang H.; Tu S.; Gong F.; Liu Y.; Wei Y.; Dong C.; Zhou F.; Gu X.; Xu J.; Liu Z.; Zhang Y.; Li H.; Shang L.; Wang K.; Li K.; Zhou X.; Dong X.; Qu Z.; Lu S.; Hu X.; Ruan S.; Luo S.; Wu J.; Peng L.; Cheng F.; Pan L.; Zou J.; Jia C.; Wang J.; Liu X.; Wang S.; Wu X.; Ge Q.; He J.; Zhan H.; Qiu F.; Guo L.; Huang C.; Jaki T.; Hayden F.G.; Horby P.W.; Zhang D.; Wang C.; A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020,82(19),1787-1799","journal-title":"N Engl J Med"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","volume":"19","author":"Arabi Y.M.","year":"2018","unstructured":"Arabi Y.M.; Alothman A.; Balkhy H.H.; Al-Dawood A.; AlJohani S.; Al Harbi S.; Kojan S.; Al Jeraisy M.; Deeb A.M.; Assiri A.M.; Al-Hameed F.; AlSaedi A.; Mandourah Y.; Almekhlafi G.A.; Sherbeeni N.M.; Elzein F.E.; Memon J.; Taha Y.; Almotairi A.; Maghrabi K.A.; Qushmaq I.; Al Bshabshe A.; Kharaba A.; Shalhoub S.; Jose J.; Fowler R.A.; Hayden F.G.; Hussein M.A.; And the MIRACLE trial group. Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 2018,19(1),81","journal-title":"Trials"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"Chu C.M.","year":"2004","unstructured":"Chu C.M.; Cheng V.C.C.; Hung I.F.N.; Wong M.M.L.; Chan K.H.; Chan K.S.; Kao R.Y.T.; Poon L.L.M.; Wong C.L.P.; Guan Y.; Peiris J.S.; Yuen K.Y.; Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax HKU\/UCH SARS Study Group2004,59(3),252-256","journal-title":"Thorax"},{"key":"ref=102","first-page":"399","volume":"9","author":"Chan K.S.","year":"2003","unstructured":"Chan K.S.; Lai S.T.; Chu C.M.; Tsui E.; Tam C.Y.; Wong M.M.; Tse M.W.; Que T.L.; Peiris J.S.; Sung J.; Wong V.C.; Yuen K.Y.; Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003,9(6),399-406","journal-title":"Hong Kong Med J"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"Li G.","year":"2019","unstructured":"Li G.; De Clercq E.; Therapeutic Options for the 2019\nNovel Coronavirus (2019-NCoV). Nat Rev Drug Discov 2019,19(3),149-150","journal-title":"Nat Rev Drug Discov"},{"key":"ref=104","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104545","volume":"169","author":"Mifsud E.J.","year":"2019","unstructured":"Mifsud E.J.; Hayden F.G.; Hurt A.C.; Antivirals targeting the polymerase complex of influenza viruses. Antiviral Res 2019,169","journal-title":"Antiviral Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/d41586-020-00444-3","volume":"578","author":"Maxmen A.","year":"2020","unstructured":"Maxmen A.; More than 80 clinical trials launch to test coronavirus treatments. Nature 2020,578(7795),347-348","journal-title":"Nature"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","volume":"153","author":"Delang L.","year":"2018","unstructured":"Delang L.; Abdelnabi R.; Neyts J.; Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res 2018,153,85-94","journal-title":"Antiviral Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Furuta Y.","year":"2017","unstructured":"Furuta Y.; Komeno T.; Nakamura T.; Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad, Ser B, Phys Biol Sci 2017,93(7),449-463","journal-title":"Proc Jpn Acad, Ser B, Phys Biol Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1073\/pnas.1617020114","volume":"114","author":"Kadam R.U.","year":"2017","unstructured":"Kadam R.U.; Wilson I.A.; Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci USA 2017,114(2),206-214","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr\u00fcger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N-H.; Nitsche A.; M\u00fcller M.A.; Drosten C.; P\u00f6hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"author":"Hoffmann M.","key":"ref=110","doi-asserted-by":"publisher","unstructured":"Hoffmann M.; Kleine-Weber H.; Kr\u00fcger N.; Mueller M.A.; Drosten C.; P\u00f6hlmann S.; The novel coronavirus\n2019 (2019-NCoV) uses the SARS-coronavirus receptor\nACE2 and the cellular protease TMPRSS2 for entry into\ntarget cells. Biorxiv, preprint article.","DOI":"10.1101\/2020.01.31.929042"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1128\/JVI.01429-16","volume":"90","author":"Coleman C.M.","year":"2016","unstructured":"Coleman C.M.; Sisk J.M.; Mingo R.M.; Nelson E.A.; White J.M.; Frieman M.B.; Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. J Virol 2016,90(19),8924-8933","journal-title":"J Virol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"15470","DOI":"10.1073\/pnas.0406821101","volume":"101","author":"Feire A.L.","year":"2004","unstructured":"Feire A.L.; Koss H.; Compton T.; Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA 2004,101(43),15470-15475","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.virol.2007.09.012","volume":"370","author":"Xiao J.","year":"2008","unstructured":"Xiao J.; Palefsky J.M.; Herrera R.; Berline J.; Tugizov S.M.; The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology 2008,370(2),430-442","journal-title":"Virology"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.127.1.257","volume":"127","author":"Wickham T.J.","year":"1994","unstructured":"Wickham T.J.; Filardo E.J.; Cheresh D.A.; Nemerow G.R.; Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994,127(1),257-264","journal-title":"J Cell Biol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00705-015-2579-8","volume":"160","author":"Hussein H.A.","year":"2015","unstructured":"Hussein H.A.; Walker L.R.; Abdel-Raouf U.M.; Desouky S.A.; Montasser A.K.M.; Akula S.M.; Beyond RGD: virus interactions with integrins. Arch Virol 2015,160(11),2669-2681","journal-title":"Arch Virol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/anie.201707948","volume":"57","author":"Hatley R.J.D.","year":"2018","unstructured":"Hatley R.J.D.; Macdonald S.J.F.; Slack R.J.; Le J.; Ludbrook S.B.; Lukey P.T.; An \u03b1v-RGD integrin inhibitor toolbox: drug discovery insight, challenges and opportunities. Angew Chem Int Ed Engl 2018,57(13),3298-3321","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111602","volume":"182","author":"Kumar R.","year":"2019","unstructured":"Kumar R.; Harilal S.; Gupta S.V.; Jose J.; Thomas Parambi D.G.; Uddin M.S.; Shah M.A.; Mathew B.; Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work. Eur J Med Chem 2019,182","journal-title":"Eur J Med Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","volume":"20","author":"Stebbing J.","year":"2020","unstructured":"Stebbing J.; Phelan A.; Griffin I.; Tucker C.; Oechsle O.; Smith D.; Richardson P.; COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020,20(4),400-402","journal-title":"Lancet Infect Dis"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"Wang M.","year":"2020","unstructured":"Wang M.; Cao R.; Zhang L.; Yang X.; Liu J.; Xu M.; Shi Z.; Hu Z.; Zhong W.; Xiao G.; Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020,30(3),269-271","journal-title":"Cell Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"Gao J.","year":"2020","unstructured":"Gao J.; Tian Z.; Yang X.; Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020,14(1),72-73","journal-title":"Biosci Trends"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5114\/reum.2018.76904","volume":"56","author":"Ha\u0142adyj E.","year":"2018","unstructured":"Ha\u0142adyj E.; Sikora M.; Felis-Giemza A.; Olesi\u0144ska M.; Antimalarials - are they effective and safe in rheumatic diseases? Reumatologia 2018,56(3),164-173","journal-title":"Reumatologia"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1128\/AAC.01509-08","volume":"53","author":"Keyaerts E.","year":"2009","unstructured":"Keyaerts E.; Li S.; Vijgen L.; Rysman E.; Verbeeck J.; Van Ranst M.; Maes P.; Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother 2009,53(8),3416-3421","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"Vincent M.J.","year":"2005","unstructured":"Vincent M.J.; Bergeron E.; Benjannet S.; Erickson B.R.; Rollin P.E.; Ksiazek T.G.; Seidah N.G.; Nichol S.T.; Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005,2,69","journal-title":"Virol J"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","volume":"3","author":"Savarino A.","year":"2003","unstructured":"Savarino A.; Boelaert J.R.; Cassone A.; Majori G.; Cauda R.; Effects of chloroquine on viral infections: an old drug against today\u2019s diseases? Lancet Infect Dis 2003,3(11),722-727","journal-title":"Lancet Infect Dis"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","volume":"100","author":"Hempelmann E.","year":"2007","unstructured":"Hempelmann E.; Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitol Res 2007,100(4),671-676","journal-title":"Parasitol Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; Li X.; Yang B.; Song J.; Zhao X.; Huang B.; Shi W.; Lu R.; Niu P.; Zhan F.; Ma X.; Wang D.; Xu W.; Wu G.; Gao G.F.; Tan W.; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nantod.2019.02.005","volume":"25","author":"Wolfram J.","year":"2019","unstructured":"Wolfram J.; Ferrari M.; Clinical cancer nanomedicine. Nano Today 2019,25,85-98","journal-title":"Nano Today"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.devcel.2015.03.002","volume":"33","author":"Miller S.E.","year":"2015","unstructured":"Miller S.E.; Mathiasen S.; Bright N.A.; Pierre F.; Kelly B.T.; Kladt N.; Schauss A.; Merrifield C.J.; Stamou D.; H\u00f6ning S.; Owen D.J.; CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature. Dev Cell 2015,33(2),163-175","journal-title":"Dev Cell"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","volume":"15","author":"Hu T.Y.","year":"2020","unstructured":"Hu T.Y.; Frieman M.; Wolfram J.; Insights from nanomedicine into chloroquine efficacy against COVID-19. Nat Nanotechnol 2020,15(4),247-249","journal-title":"Nat Nanotechnol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"Yao X.","year":"2020","unstructured":"Yao X.; Ye F.; Zhang M.; Cui C.; Huang B.; Niu P.; Liu X.; Zhao L.; Dong E.; Song C.; Zhan S.; Lu R.; Li H.; Tan W.; Liu D.; In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020,71(15),732-739","journal-title":"Clin Infect Dis"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"Liu J.","year":"2020","unstructured":"Liu J.; Cao R.; Xu M.; Wang X.; Zhang H.; Hu H.; Li Y.; Hu Z.; Zhong W.; Wang M.; Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 2020,6,16","journal-title":"Cell Discov"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","volume":"75","author":"McChesney E.W.","year":"1983","unstructured":"McChesney E.W.; Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 1983,75(1A),11-18","journal-title":"Am J Med"},{"key":"ref=133","unstructured":"Search of COVID-19 - search details at ClinicalTrials.gov.\nAvailable at:  [accessed on: May 19, 2020]."},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v12030254","volume":"12","author":"Ahmed S.F.","year":"2020","unstructured":"Ahmed S.F.; Quadeer A.A.; McKay M.R.; Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 2020,12(3),254","journal-title":"Viruses"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","volume":"52","author":"Amanat F.","year":"2020","unstructured":"Amanat F.; Krammer F.; SARS-CoV-2 vaccines: status report. Immunity 2020,52(4),583-589","journal-title":"Immunity"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMp2005630","volume":"382","author":"Lurie N.","year":"2020","unstructured":"Lurie N.; Saville M.; Hatchett R.; Halton J.; Developing Covid-19 vaccines at pandemic speed. N Engl J Med 2020,382(21),1969-1973","journal-title":"N Engl J Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chom.2020.04.021","volume":"27","author":"Diamond M.S.","year":"2020","unstructured":"Diamond M.S.; Pierson T.C.; The Challenges of vaccine development against a new virus during a pandemic. Cell Host Microbe 2020,27(5),699-703","journal-title":"Cell Host Microbe"},{"key":"ref=138","unstructured":"Side effects halt use of chloroquine vs. COVID\u201019. Available\nat:  [accessed on:\nMay 19, 2020]."},{"key":"ref=139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd013587.pub2","author":"Singh B.","year":"2020","unstructured":"Singh B.; Ryan H.; Kredo T.; Chaplin M.; Fletcher T.; Chloroquine or hydroxychloroquine for prevention and\ntreatment of COVID\u201019. Cochrane Database Syst Rev (2), CD013587.2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=140","unstructured":"COVID-19: reminder of risk serious side effects with chloroquine\nand hydroxychloroquine. Available at:  [accessed on: May 19, 2020]."}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200702151018","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183407\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200702151018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T07:50:43Z","timestamp":1655797843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183407\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":140,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200702151018","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}